Search Clinical Trials
Return to search results.
A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer
| |
|
NSABP B-47 |
| | | |
| |
|
Tanya Wahl, MD |
| | | |
| |
|
III |
Look up trial at NIH
| |
|
NSABP B-47 |
| | | |
| |
|
Nancy Knudsen, RN |
| | | |
| |
|
206/667-4692 |
| | | |
|
|
|
Breast Cancer; Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Please remember:
- Talk to your health care providers first before making decisions about your health care.
- Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.
